This study differentiates a primary hemorrhagic disorder of platelet dysfunction from aspirin-induced defects based on distinct aggregation and adhesion profiles.
Answers are grounded in this paper and cite their sources.
Distinguishes primary platelet dysfunction from aspirin effects in bleeding patients; hypothesis-generating for targeted testing pending larger validation studies.
A recently described hemorrhagic disorder characterized by defective platelet aggregation induced by collagen and epinephrine appears to be caused, in part, by the same abnormality induced by aspirin ingestion — that is, inhibition of release of intrinsic platelet adenosine diphosphate (ADP). In contrast to the aspirin-induced defect, bleeding time was greatly prolonged, platelet adhesiveness was markedly impaired, adhesion of platelets to collagen fibrils was deficient, and aggregation of platelets by serotonin and glass beads was impaired. Both phases of epinephrine-induced platelet aggregation were blocked, whereas with aspirin only the second phase was absent. There was rapid disaggregation after low-molar ADP whereas with aspirin the rate was only slightly increased. As with the aspirin-induced platelet abnormality aggregation of platelets by trypsin, collagen and centrifugation was blocked, but aggregation by high-molar ADP and thrombin was normal. Platelet transfusions temporarily corrected most of the defects.
No takes yet. Share an insight, caveat, or question.
Sahud et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: